The tariff classification of Abacavir Sulfate (CAS-188062-50-2), imported in bulk form, and Ziagen™ (abacavir sulfate) tablets and Ziagen™ (abacavir sulfate) Oral Solution, from various countries, including the United Kingdom, France, Italy, Canada, and Singapore
Issued September 18, 2000 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.90.9010, 2933.59.5900
Product description
Abacavir Sulfate, your client’s brand name for which is Ziagen™, is an antiviral drug. It is the active ingredient in Ziagen™ (abacavir sulfate) tablets and Ziagen™ (abacavir sulfate) Oral Solution which, according to your client’s monograph appearing in the 2000 Physicians’ Desk Reference®, are used to treat HIV infection.
CBP rationale
The applicable subheading for Abacavir Sulfate, imported in bulk form, will be 2933.59.5900, Harmonized Tariff Schedule of the United States (HTS), which provides for "[H]eterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: Other: Drugs: Other. The applicable subheading for Ziagen™ (abacavir sulfate) tablets and Ziagen™ (abacavir sulfate) Oral Solution will be 3004.90.9010, HTS, which provides for “[M]edicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale: Other: Other: Other: Anti-infective medicaments: Other.
Full text
NY G81508 September 18, 2000 CLA-2-29:RR:NC:2:238 G81508 CATEGORY: Classification TARIFF NO.: 2933.59.5900; 3004.90.9010 Robert L. Eisen, Esq. Christopher E. Pey, Esq. Coudert Brothers 1114 Avenue of the Americas New York, NY 10036-7703 RE: The tariff classification of Abacavir Sulfate (CAS-188062-50-2), imported in bulk form, and Ziagen™ (abacavir sulfate) tablets and Ziagen™ (abacavir sulfate) Oral Solution, from various countries, including the United Kingdom, France, Italy, Canada, and Singapore Dear Messrs. Eisen and Pey: In your letter dated August 3, 2000, on behalf of your client, Glaxo Wellcome Inc., you requested a tariff classification ruling. Abacavir Sulfate, your client’s brand name for which is Ziagen™, is an antiviral drug. It is the active ingredient in Ziagen™ (abacavir sulfate) tablets and Ziagen™ (abacavir sulfate) Oral Solution which, according to your client’s monograph appearing in the 2000 Physicians’ Desk Reference®, are used to treat HIV infection. The applicable subheading for Abacavir Sulfate, imported in bulk form, will be 2933.59.5900, Harmonized Tariff Schedule of the United States (HTS), which provides for "[H]eterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: Other: Drugs: Other." Pursuant to General Note 13, HTS, the rate of duty will be free. The applicable subheading for Ziagen™ (abacavir sulfate) tablets and Ziagen™ (abacavir sulfate) Oral Solution will be 3004.90.9010, HTS, which provides for “[M]edicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale: Other: Other: Other: Anti-infective medicaments: Other.” The general rate of duty will be free. This merchandise may be subject to the requirements of the Federal Food, Drug, and Cosmetic Act, which is administered by the U.S. Food and Drug Administration. You may contact them at 5600 Fishers Lane, Rockville, Maryland 20857, telephone number 301-443-1544. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 212-637-7068. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan
The tariff classification of Acyclovir (CAS No. 59277-89-3) in bulk form, from Spain
The tariff classification of Imatinib (CAS No. 152459-95-5) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk powder form, from Italy
The tariff classification of Minoxidil (CAS No. 38304-91-5) in bulk powder form, from Italy
The tariff classification of Tipiracil Hydrochloride (CAS No. 183204-72-0) in bulk powder form, from Italy
The tariff classification of Tofacitinib Citrate (CAS 540737-29-9), imported in bulk powder form, from Spain
The tariff classification of Dipyridamole (CAS-58-32-2) in bulk form, from India
The tariff classification of Sapropterin Dihydrochloride (CAS-69056-38-8) in bulk form, from Italy
The tariff classification of Entecavir (CAS-142217-69-4), in bulk form, from India
The tariff classification of Allopurinol (CAS-315-30-0) in bulk form, from Spain
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →